PUBLISHER: Grand View Research | PRODUCT CODE: 1529824
PUBLISHER: Grand View Research | PRODUCT CODE: 1529824
The global pulse oximeter market size is expected to reach USD 5.3 billion by 2030, registering a CAGR of 6.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of respiratory and cardiovascular diseases globally is anticipated to boost the demand for continuous monitoring devices, such as pulse oximeters. According to the National Center for Health Statistics, in 2022, 4.6% of the U.S. population over 18 years suffered from emphysema, COPD, or chronic bronchitis. Moreover, factors such as technological advancements, strategic partnerships among key players, and the rising adoption of home healthcare & remote patient monitoring are driving the pulse oximeters market growth.
Furthermore, market conglomerates are forming strategic alliances to penetrate untapped markets and establish their global presence. These partnerships aim to offer precise, real-time health data, bolster patient involvement, and facilitate clinical decision-making, thereby enhancing patient care quality as well as streamlining healthcare services. For instance, in January 2023, Royal Philips and Masimo expanded their partnership to improve patient monitoring capabilities in home telehealth settings by deploying the Masimo W1, an advanced health-tracking device.
"Expanding our partnership with Philips in this way is a win-win for patients and clinicians everywhere, and is an important part of our multi-year plan to bring the best of hospital monitoring to the home while continuing to improve access to quality hospital care."
Bilal Muhsin, Chief Operating Officer, Masimo
Moreover, wearable pulse oximeters like socks provide continuous monitoring, making them ideal for tracking an infant's SpO2 levels. These devices offer comfort and convenience, facilitating regular use. For instance, in June 2023, Owlet received U.S. FDA clearance for BabySat, an advanced pulse oximetry medical device. This device, featuring an innovative, wire-free sock design, continuously monitors an infant's heart rate and oxygen levels (SpO2) and alerts parents if these measurements deviate from established norms.
In developed countries, there is a rising trend of surgical patients requiring intensive postoperative monitoring. Traditionally managed in post-anesthesia or surgical Intensive Care Units (ICUs), resource constraints often lead to premature transfer of patients to general wards, where continuous monitoring may be inadequate. Inadequate monitoring in general wards, where nurse-to-patient ratios can reach 1:20 during nighttime, increases the risk of complications going unnoticed. Studies indicate that postoperative complications contribute significantly to hospital mortality rates. With recognition of the risk of undiagnosed hypoxemia and the impact of postoperative complications on patient outcomes, the demand for pulse oximeters to enhance monitoring and mitigate risks during postoperative care is increasing.
Furthermore, the adoption of pulse oximeters is expected to increase in outpatient settings, such as ambulatory surgical centers and physician offices, due to their convenience and the growing importance of patient monitoring. These facilities are opting for portable, handheld models to enable continuous monitoring without restricting patient mobility, aligning with the shift toward value-based care that emphasizes effective and cost-efficient monitoring solutions.